echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Duodi Gleevec takes the initiative to reduce the price

    Duodi Gleevec takes the initiative to reduce the price

    • Last Update: 2019-03-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, affected by 4 + 7, several unselected drugs have been reduced in price The imatinib mesylate tablets originally developed by Novartis have also applied for price reduction in many places before, such as Shanghai, Shaanxi, Liaoning, Yunnan and other places have issued price adjustment announcements, and the specification of 0.1g * 60 Tablets has been reduced from 9998 yuan / box to 7182 yuan / box On March 26, Gansu Province issued a notice that the bid winning price of imatinib mesylate tablets (Gleevec, serial number 1111894, 0.1g * 60), which was agent of Beijing Novartis Pharmaceutical Co., Ltd., was reduced from 9998 yuan / box to 7182 yuan / box on the centralized procurement platform in Gansu Province, and the adjusted price was implemented in the whole province from April 1, 2019 Meanwhile, the original agency right of the product was changed from Gansu heavy Pharmaceutical Co., Ltd to Beijing Novartis Pharmaceutical Co., Ltd Recently, affected by 4 + 7, several unselected drugs have been reduced in price The imatinib mesylate tablets originally developed by Novartis have also applied for price reduction in many places before, such as Shanghai, Shaanxi, Liaoning, Yunnan and other places have issued price adjustment announcements, and the specification of 0.1g * 60 Tablets has been reduced from 9998 yuan / box to 7182 yuan / box.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.